OncoLink reporters provide in-depth coverage of scientific presentations from the 43rd Annual ASCO Meeting.
Jun 2, 2015
Ibrutinib, obinutuzumab slow progression of CLL, non-Hodgkin's lymphoma
Second study supports new immunotherapy for enhanced survival in advanced melanoma
Jun 11, 2013
From 1998 to 2007, more scans for married, non-black, <80-year-old patients with lung cancer